Team

Leadership Team

• 

  Jessica Weaver, PhD

  Chief Scientific Officer

  15 years of experience in cell transplantation and biomaterial development, conceived the technology platforms licensed by ImmunoShield Therapeutics.

• 

  Matthew Becker, PhD

  Chief Executive Officer

  Expertise in biomaterials and immune engineering technology platforms, helped secure over $2M in non-dilutive funding.

• 

  Oren Snir, JD MBA

  Chief Operating Officer

  Business management experience, legal experience in data privacy and technology transactions.

Strategic Advisors

• 

  Holger Russ, PhD

  Scientific Advisor

  Pioneer in stem cell-derived beta cell generation, previous biotech co-founder, previous experience on a clinical advisory board for pharma.

• 

  Randy Vane

  Mentor

  Deep experience in pharma partnerships with a background in digital health technology.

• 

  Patti DuBois

  Business Advisor (informal) at CEI

  Assistant Executive Director, Center for Entrepreneurial Innovation, expertise in commercialization and funding.

Why This Team Wins

• Deep Scientific Expertise

  15+ years combined experience in cell transplantation, biomaterials, and immune engineering. Technology platforms conceived and developed by team members.

  • 50+ peer-reviewed publications
  • Multiple patents granted and pending
  • Track record of successful technology translation

• Proven Commercialization Skills

  Successful track record securing non-dilutive funding, building strategic partnerships, and navigating regulatory pathways.

  • $2.1M+ non-dilutive funding secured
  • NSF I-Corps trained
  • Experience with FDA processes

• Strategic Network

  Strong connections to key opinion leaders in cell therapy, pharma executives, and potential strategic partners.

  • 20+ pharma relationships established
  • Academic partnerships at top institutions
  • Access to manufacturing expertise